Synovial Sarcoma, X Breakpoint 7 (SSX7) Peptid
SSX7
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN939345
Kurzübersicht für Synovial Sarcoma, X Breakpoint 7 (SSX7) Peptid (ABIN939345)
Target
SSX7
(Synovial Sarcoma, X Breakpoint 7 (SSX7))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- IFPKIMPKKP AEEGNDSKGV PEASGSQNDG KHLCPPGKPS TSEKINKTSG
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SSX7 antibody,
Alternative Names: SSX7 control peptide, SSX7 antibody Blocking Peptide, Anti-SSX7 Blocking Peptide, synovial sarcoma, X breakpoint 7 Blocking Peptide, SSX7, SSX-7, SSX 7, SSX-7 Blocking Peptide, SSX 7 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))
-
Hintergrund
- SSX7 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas.
-
Molekulargewicht
- 21 kDa
Target
-
Sie sind hier:
